메뉴 건너뛰기




Volumn 36, Issue SUPPL. 2, 2007, Pages 69-79

Future directions for insulin therapy and diabetes treatment

Author keywords

[No Author keywords available]

Indexed keywords

CPE 215; DRUG VEHICLE; HUMAN INSULIN; INSULIN; INSULIN DERIVATIVE; INSULIN GLULISINE; INSULIN LISPRO; ORAL ANTIDIABETIC AGENT; PLACEBO; RECOMBINANT HUMAN INSULIN; TECHNOSPHERE; UNCLASSIFIED DRUG; VIAJECT;

EID: 41849085942     PISSN: 08898529     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0889-8529(07)80012-0     Document Type: Article
Times cited : (5)

References (33)
  • 2
    • 33845341470 scopus 로고    scopus 로고
    • Impact of recent increase in incidence on future diabetes burden: U.S. 2005-2050
    • Narayan K., Boyle J., Geiss L., et al. Impact of recent increase in incidence on future diabetes burden: U.S. 2005-2050. Diabetes Care 29 (2006) 2114-2116
    • (2006) Diabetes Care , vol.29 , pp. 2114-2116
    • Narayan, K.1    Boyle, J.2    Geiss, L.3
  • 3
    • 41849148860 scopus 로고    scopus 로고
    • National Diabetes Surveillance System. Diabetes data and trends: age-adjusted percentage of adults with diabetes using diabetes medication, by type of medication, United States, 1997-2003. Centers for Disease Control and Prevention Accessed October 15, 2007
    • National Diabetes Surveillance System. Diabetes data and trends: age-adjusted percentage of adults with diabetes using diabetes medication, by type of medication, United States, 1997-2003. Centers for Disease Control and Prevention. http://www.cdc.gov/diabetes/statistics/meduse/fig2.htm Accessed October 15, 2007
  • 4
    • 33744968835 scopus 로고    scopus 로고
    • Achievement of American Diabetes Association clinical practice recommendations among U.S. adults with diabetes, 1999-2002: the National Health and Nutrition Examination Survey
    • Resnick H., Foster G., Bardsley J., and Ratner R. Achievement of American Diabetes Association clinical practice recommendations among U.S. adults with diabetes, 1999-2002: the National Health and Nutrition Examination Survey. Diabetes Care 29 (2006) 531-537
    • (2006) Diabetes Care , vol.29 , pp. 531-537
    • Resnick, H.1    Foster, G.2    Bardsley, J.3    Ratner, R.4
  • 5
    • 0036736185 scopus 로고    scopus 로고
    • When oral agents fail: practical barriers to starting insulin
    • Korytkowski M. When oral agents fail: practical barriers to starting insulin. Int J Obes Relat Metab Disord 26 Suppl 3 (2002) S18-S24
    • (2002) Int J Obes Relat Metab Disord , vol.26 , Issue.SUPPL. 3
    • Korytkowski, M.1
  • 6
    • 41849117551 scopus 로고    scopus 로고
    • A regular human insulin formulation with a more rapid onset of action than rapid-acting insulin analogues
    • Accessed October 15, 2007
    • Steiner S., Hompesch M., Pohl R., and Simms P. A regular human insulin formulation with a more rapid onset of action than rapid-acting insulin analogues. Insulin Congress Abstracts: The Evolving Science and Practice of Insulin Therapy 2 Suppl A (2007) S21. http://www.insulinjournal.com/Images/pdfs/Insulin_s2_11_Other.pdf Accessed October 15, 2007
    • (2007) Insulin Congress Abstracts: The Evolving Science and Practice of Insulin Therapy , vol.2 , Issue.SUPPL. A
    • Steiner, S.1    Hompesch, M.2    Pohl, R.3    Simms, P.4
  • 7
    • 41849150285 scopus 로고    scopus 로고
    • Intra-dermal insulin lispro application with a new microneedle delivery system led to a substantially more rapid insulin absorption than subcutaneous injection: P909
    • Heinemann L., Hompesch M., Kapitza C., et al. Intra-dermal insulin lispro application with a new microneedle delivery system led to a substantially more rapid insulin absorption than subcutaneous injection: P909. Diabetic Med 23 Suppl 4 (2006) 329
    • (2006) Diabetic Med , vol.23 , Issue.SUPPL. 4 , pp. 329
    • Heinemann, L.1    Hompesch, M.2    Kapitza, C.3
  • 8
    • 1042291852 scopus 로고    scopus 로고
    • Concept, strategies, and feasibility of noninvasive insulin delivery
    • Cefalu W. Concept, strategies, and feasibility of noninvasive insulin delivery. Diabetes Care 27 (2004) 239-246
    • (2004) Diabetes Care , vol.27 , pp. 239-246
    • Cefalu, W.1
  • 9
    • 0023131817 scopus 로고
    • On the way to the automated (blood) glucose regulation in diabetes: the dark past, the grey present and the rosy future. XII Congress of the International Diabetes Federation, Madrid, Spain, 1985
    • Pfeiffer E. On the way to the automated (blood) glucose regulation in diabetes: the dark past, the grey present and the rosy future. XII Congress of the International Diabetes Federation, Madrid, Spain, 1985. Diabetologia 30 (1987) 51-65
    • (1987) Diabetologia , vol.30 , pp. 51-65
    • Pfeiffer, E.1
  • 10
    • 11844250564 scopus 로고    scopus 로고
    • Insulin analogues
    • Hirsch I. Insulin analogues. N Engl J Med 352 (2005) 174-183
    • (2005) N Engl J Med , vol.352 , pp. 174-183
    • Hirsch, I.1
  • 11
    • 42749106543 scopus 로고    scopus 로고
    • Short acting insulin analogues versus regular human insulin in patients with diabetes mellitus
    • Apr 19:CD003287
    • Siebenhofer A., Plank J., Berghold A., et al. Short acting insulin analogues versus regular human insulin in patients with diabetes mellitus. Cochrane Database Syst Rev (2006) Apr 19:CD003287
    • (2006) Cochrane Database Syst Rev
    • Siebenhofer, A.1    Plank, J.2    Berghold, A.3
  • 12
    • 22144484165 scopus 로고    scopus 로고
    • Systematic review and meta-analysis of short-acting insulin analogues in patients with diabetes mellitus
    • Plank J., Siebenhofer A., Berghold A., et al. Systematic review and meta-analysis of short-acting insulin analogues in patients with diabetes mellitus. Arch Intern Med 165 (2005) 1337-1344
    • (2005) Arch Intern Med , vol.165 , pp. 1337-1344
    • Plank, J.1    Siebenhofer, A.2    Berghold, A.3
  • 13
    • 31844437604 scopus 로고    scopus 로고
    • Self-monitoring of blood glucose in type 2 diabetes and long-term outcome: an epidemiological cohort study
    • Martin S., Schneider B., Heinemann L., et al. Self-monitoring of blood glucose in type 2 diabetes and long-term outcome: an epidemiological cohort study. Diabetologia 49 (2006) 271-278
    • (2006) Diabetologia , vol.49 , pp. 271-278
    • Martin, S.1    Schneider, B.2    Heinemann, L.3
  • 15
    • 41849122554 scopus 로고    scopus 로고
    • Biodel Inc. announces VIAject™ data at oral presentation at the American Diabetes Association meeting [press release]. Biodel Inc., Danbury Conn; June 22, 2007 Accessed October 15, 2007
    • Biodel Inc. announces VIAject™ data at oral presentation at the American Diabetes Association meeting [press release]. Biodel Inc., Danbury Conn; June 22, 2007. http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=109&STORY=/www/sto ry/06-22-2007/0004613899&EDATE= Accessed October 15, 2007
  • 16
    • 0035349026 scopus 로고    scopus 로고
    • Impact of diabetic nephropathy on pharmacodynamic and pharmacokinetic properties of insulin in type 1 diabetic patients
    • Rave K., Heise T., Pfützner A., et al. Impact of diabetic nephropathy on pharmacodynamic and pharmacokinetic properties of insulin in type 1 diabetic patients. Diabetes Care 24 (2001) 886-890
    • (2001) Diabetes Care , vol.24 , pp. 886-890
    • Rave, K.1    Heise, T.2    Pfützner, A.3
  • 17
    • 34547879624 scopus 로고    scopus 로고
    • Insulin glulisine: a faster onset of action compared with insulin lispro
    • Heise T., Nosek L., Spitzer H., et al. Insulin glulisine: a faster onset of action compared with insulin lispro. Diabetes Obes Metab 9 (2007) 746-753
    • (2007) Diabetes Obes Metab , vol.9 , pp. 746-753
    • Heise, T.1    Nosek, L.2    Spitzer, H.3
  • 18
    • 25644437167 scopus 로고    scopus 로고
    • Dose response of inhaled dry-powder insulin and dose equivalence to subcutaneous insulin lispro
    • Rave K., Nosek L., de la Pena A., et al. Dose response of inhaled dry-powder insulin and dose equivalence to subcutaneous insulin lispro. Diabetes Care 28 (2005) 2400-2405
    • (2005) Diabetes Care , vol.28 , pp. 2400-2405
    • Rave, K.1    Nosek, L.2    de la Pena, A.3
  • 19
    • 18144368866 scopus 로고    scopus 로고
    • Time-action profile of inhaled insulin in comparison with subcutaneously injected insulin lispro and regular human insulin
    • Rave K., Bott S., Heinemann L., et al. Time-action profile of inhaled insulin in comparison with subcutaneously injected insulin lispro and regular human insulin. Diabetes Care 28 (2005) 1077-1082
    • (2005) Diabetes Care , vol.28 , pp. 1077-1082
    • Rave, K.1    Bott, S.2    Heinemann, L.3
  • 20
    • 0036025088 scopus 로고    scopus 로고
    • Technosphere/Insulin-a new approach for effective delivery of human insulin via the pulmonary route
    • Pfützner A., Mann A., and Steiner S. Technosphere/Insulin-a new approach for effective delivery of human insulin via the pulmonary route. Diabetes Technol Ther 4 (2002) 589-594
    • (2002) Diabetes Technol Ther , vol.4 , pp. 589-594
    • Pfützner, A.1    Mann, A.2    Steiner, S.3
  • 21
    • 33748765784 scopus 로고    scopus 로고
    • ®) improve management of type 2 diabetes? The design of the Real World trial
    • for the Real World Trialists Accessed October 15, 2007
    • ®) improve management of type 2 diabetes? The design of the Real World trial. Trials 7 (2006) 25. http://www.trialsjournal.com/content/7/1/25 Accessed October 15, 2007
    • (2006) Trials , vol.7 , pp. 25
    • Freemantle, N.1    Strack, T.2
  • 22
    • 16844382684 scopus 로고    scopus 로고
    • Oral delivery of insulin with the eligen technology: mechanistic studies
    • Malkov D., Angelo R., Wang H., et al. Oral delivery of insulin with the eligen technology: mechanistic studies. Curr Drug Deliv 2 (2005) 191-197
    • (2005) Curr Drug Deliv , vol.2 , pp. 191-197
    • Malkov, D.1    Angelo, R.2    Wang, H.3
  • 23
    • 11144254615 scopus 로고    scopus 로고
    • Oral spray insulin in treatment of type 2 dia-betes: a comparison of efficacy of the oral spray insulin (Oralin) with subcutaneous (SC) insulin injection, a proof of concept study
    • Guevara-Aguirre J., Guevara M., Saavedra J., et al. Oral spray insulin in treatment of type 2 dia-betes: a comparison of efficacy of the oral spray insulin (Oralin) with subcutaneous (SC) insulin injection, a proof of concept study. Diabetes Metab Res Rev 20 (2004) 472-478
    • (2004) Diabetes Metab Res Rev , vol.20 , pp. 472-478
    • Guevara-Aguirre, J.1    Guevara, M.2    Saavedra, J.3
  • 24
    • 0023244003 scopus 로고
    • Effects of intranasal insulin in non-obese type II diabetics
    • Frauman A., Jerums G., and Louis W. Effects of intranasal insulin in non-obese type II diabetics. Diabetes Res Clin Pract 3 (1987) 197-202
    • (1987) Diabetes Res Clin Pract , vol.3 , pp. 197-202
    • Frauman, A.1    Jerums, G.2    Louis, W.3
  • 25
    • 0021918027 scopus 로고
    • Intranasal aerosolized insulin Mixed-meal studies and long-term use in type I diabetes
    • Salzman R., Manson J., Griffing G., et al. Intranasal aerosolized insulin Mixed-meal studies and long-term use in type I diabetes. N Engl J Med 312 (1985) 1078-1084
    • (1985) N Engl J Med , vol.312 , pp. 1078-1084
    • Salzman, R.1    Manson, J.2    Griffing, G.3
  • 26
    • 0034845659 scopus 로고    scopus 로고
    • Efficacy and tolerance of intranasal insulin administered during 4 months in severely hyperglycaemic type 2 diabetic patients with oral drug failure: a cross-over study
    • Lalej-Bennis D., Boillot J., Bardin C., et al. Efficacy and tolerance of intranasal insulin administered during 4 months in severely hyperglycaemic type 2 diabetic patients with oral drug failure: a cross-over study. Diabet Med 18 (2001) 614-618
    • (2001) Diabet Med , vol.18 , pp. 614-618
    • Lalej-Bennis, D.1    Boillot, J.2    Bardin, C.3
  • 27
    • 0034942194 scopus 로고    scopus 로고
    • Six month administration of gelified intranasal insulin in 16 type 1 diabetic patients under multiple injections: efficacy vs subcutaneous injections and local tolerance
    • Lalej-Bennis D., Boillot J., Bardin C., et al. Six month administration of gelified intranasal insulin in 16 type 1 diabetic patients under multiple injections: efficacy vs subcutaneous injections and local tolerance. Diabet Metab 27 (2001) 372-377
    • (2001) Diabet Metab , vol.27 , pp. 372-377
    • Lalej-Bennis, D.1    Boillot, J.2    Bardin, C.3
  • 28
    • 0028967620 scopus 로고
    • Intranasal insulin: the effects of three dose regimens on postprandial glycaemic profiles in type II diabetic subjects
    • Coates P., Ismail I., Luzio S., et al. Intranasal insulin: the effects of three dose regimens on postprandial glycaemic profiles in type II diabetic subjects. Diabet Med 12 (1995) 235-239
    • (1995) Diabet Med , vol.12 , pp. 235-239
    • Coates, P.1    Ismail, I.2    Luzio, S.3
  • 29
    • 41849100239 scopus 로고    scopus 로고
    • TransPharma Medical. The insulin human clinical trial Accessed October 15, 2007
    • TransPharma Medical. The insulin human clinical trial. http://www.transpharmamedical.com/product_apps_insulin_clinical_trial.ht ml Accessed October 15, 2007
  • 30
    • 34147147578 scopus 로고    scopus 로고
    • Implantable insulin pumps. A position statement about their clinical use
    • for the EVADIAC Group
    • Renard E., Schaepelynck-Bélicar P., and for the EVADIAC Group. Implantable insulin pumps. A position statement about their clinical use. Diabetes Metab 33 (2007) 158-166
    • (2007) Diabetes Metab , vol.33 , pp. 158-166
    • Renard, E.1    Schaepelynck-Bélicar, P.2
  • 31
    • 33750595378 scopus 로고    scopus 로고
    • Are insulin pumps underutilized in type 1 diabetes? No
    • Schade D., and Valentine V. Are insulin pumps underutilized in type 1 diabetes? No. Diabetes Care 29 (2006) 1453-1455
    • (2006) Diabetes Care , vol.29 , pp. 1453-1455
    • Schade, D.1    Valentine, V.2
  • 32
    • 33746417553 scopus 로고    scopus 로고
    • Are insulin pumps underutilized in type 1 diabetes? Yes
    • Pickup J. Are insulin pumps underutilized in type 1 diabetes? Yes. Diabetes Care 29 (2006) 1449-1452
    • (2006) Diabetes Care , vol.29 , pp. 1449-1452
    • Pickup, J.1
  • 33
    • 33845340831 scopus 로고    scopus 로고
    • OmniPod Insulin Management System: patient perceptions, preference, and glycemic control
    • Zisser H., and Jovanovic L. OmniPod Insulin Management System: patient perceptions, preference, and glycemic control. Diabetes Care 29 (2006) 2175
    • (2006) Diabetes Care , vol.29 , pp. 2175
    • Zisser, H.1    Jovanovic, L.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.